Association of DNA Promoter Methylation and <i>BRAF</i> Mutation in Thyroid Cancer
The <i>BRAF</i> V600E mutation and DNA promoter methylation play important roles in the pathogenesis of thyroid cancer (TC). However, the association of these genetic and epigenetic alterations is not clear. In this study, using paired tumor and surrounding normal tissue from the same pa...
Main Authors: | Farzana Jasmine, Briseis Aschebrook-Kilfoy, Mohammad M. Rahman, Garrett Zaagman, Raymon H. Grogan, Mohammed Kamal, Habibul Ahsan, Muhammad G. Kibriya |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/3/227 |
Similar Items
-
Developing Models to Predict <i>BRAF</i>V600E and <i>RAS</i> Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression
by: Agnes Stephanie Harahap, et al.
Published: (2023-10-01) -
Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation.
by: Yasuko eKikuchi, et al.
Published: (2013-12-01) -
Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for <i>TERT</i> Promoter Mutations
by: Sama Alohali, et al.
Published: (2023-01-01) -
Update on Fundamental Mechanisms of Thyroid Cancer
by: Alessandro Prete, et al.
Published: (2020-03-01) -
<i>BRAF</i> Inhibitors in <i>BRAF-Mutated</i> Colorectal Cancer: A Systematic Review
by: Wajeeha Aiman, et al.
Published: (2023-12-01)